Advances in Antioxidative Therapy of Multiple Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|37|4720-4730

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.37, 2013-11, pp. : 4720-4730

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Teriflunomide for oral therapy in multiple sclerosis

By Papadopoulou Athina   Kappos Ludwig   Sprenger Till  

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 617-628

Informa Healthcare

Access to resources Recommend Favorite

Basic and escalation therapy of multiple sclerosis

By  

PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. : 414-421

Govi-Verlag

Access to resources Recommend Favorite

Recent advances in preclinical drug development in multiple sclerosis

By Hoban C.J.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 831-854

Informa Healthcare

Access to resources Recommend Favorite

Advances in the Immune Pathogenesis and Treatment of Multiple Sclerosis

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 1, 2009-03 ,pp. : 20-31

Bentham Science Publishers

Access to resources Recommend Favorite

Managing the Adverse Effects of Interferon- Therapy in Multiple Sclerosis

By Bayas A.   Rieckmann P.  

Drug Safety, Vol. 22, Iss. 2, 2000-02 ,pp. : 149-159

Adis International

Access to resources Recommend Favorite